The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 3.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 7,820,590 shares of the medical device company’s stock after acquiring an additional 231,155 shares during the quarter. Cooper Companies accounts for about 1.7% of Kayne Anderson Rudnick Investment Management LLC’s portfolio, making the stock its 12th biggest holding. Kayne Anderson Rudnick Investment Management LLC’s holdings in Cooper Companies were worth $682,738,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. increased its stake in Cooper Companies by 1.2% during the 4th quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after buying an additional 41 shares in the last quarter. LRI Investments LLC lifted its holdings in Cooper Companies by 4.5% in the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after purchasing an additional 112 shares in the last quarter. Commonwealth Equity Services LLC lifted its holdings in Cooper Companies by 0.8% in the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after purchasing an additional 118 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in Cooper Companies by 4.8% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after purchasing an additional 125 shares during the last quarter. Finally, American International Group Inc. grew its holdings in shares of Cooper Companies by 1.0% during the fourth quarter. American International Group Inc. now owns 13,229 shares of the medical device company’s stock worth $5,006,000 after buying an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insider Buying and Selling at Cooper Companies

In related news, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. The disclosure for this sale can be found here. Insiders have sold a total of 256,373 shares of company stock valued at $27,637,427 over the last quarter. 2.00% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on COO shares. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird raised their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Piper Sandler upped their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average target price of $115.00.

Cooper Companies Stock Down 0.5 %

Shares of NASDAQ:COO opened at $110.49 on Friday. The company has a market capitalization of $22.00 billion, a price-to-earnings ratio of 64.99, a PEG ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The business has a 50-day moving average price of $97.93 and a 200 day moving average price of $95.54. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.